PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “outcomes”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 469 records · Page 26Linked to original sources
PubMed2000

The outcome of revision hip arthroplasty in patients older than age 80 years: complications and social outcome of different risk groups.

Between December 1995 and June 1996, we reviewed 53 consecutive patients who were at least 80 years old and had undergone a revision of a hip prosthesis between June 1988 and June 1995. Three patients (6%) had died after the operation in the hospital. Thirty-five patients were still alive with a mean follow-up of 4.0 years (range, 1.0-7.3 years). At follow-up, 15 patients had died, with a mean survival period of 25 months. Thirteen of the 15 (89%) belonged to American Society of Anesthesiologists' (ASA) group 3. Of 50 patients, 40 (80%) returned to their original social environment. Admission to a home for elderly people or to a nursing home was unrelated to the procedure in 9 of 10 cases. Complications occurred in 27 patients (51%). Major complications occurred only in high-risk patients, classified as ASA 3 according to the physical status classification of the ASA.

Age Factors↗
PubMed1997

Clinical outcomes, quality of life, and cost outcomes after cardiac transplantation.

Cardiac transplantation improves survival in patients with advanced heart failure, especially those who are dependent on intravenous inotropic support or mechanical assistance. However, cardiac transplantation remains a treatment modality rather than a curative procedure, and thus, necessitates long-term care and indefinite immunosuppression. Although quality of life is improved for most cardiac transplant recipients, concerted effort is necessary for long-term care and follow-up of the transplanted heart. The economics of cardiac transplantation are receiving increased scrutiny, especially because of the increasing pretransplant hospital expenditures that have resulted from transplantation in more patients in the hospital who require intravenous inotropic support or mechanical devices. This shift ultimately is related to the reduced supply of donors relative to the demand. The ultimate impact of managed care on cardiac transplantation is not clear, but it probably will continue to reduce expenditures in the near term.

Cost Control↗
PubMedDate not supplied

Management and outcome of stents in 1998: long-term outcome.

In the first 20 years of its existence, percutaneous transluminal coronary angioplasty (PTCA) has emerged to become the most common major medical intervention. In the meantime, many different adjunctive devices, such as drills, lasers, cutters, and suckers, have been invented, but only stents (introduced in 1986) have become a major asset to PTCA. Their main benefit is reducing the incidence of acute occlusions caused by dissection and, thus, the need for emergency bypass grafting. The approximate 30% restenosis rate of PTCA between 3 and 6 months after the intervention is also reduced to approximately 20% by stents. In the long term, ie, after 6 months, the stented or nonstented lesion is stable and needs a revascularization procedure in only 4% of the lesions. After PTCA, progression of coronary artery disease plays a dominant role, necessitating subsequent interventions for new stenoses in as many as 10% of patients.

Angioplasty, Balloon, Coronary↗